This is an investigational study. Paclitaxel is FDA approved and commercially available for the treatment of breast cancer that does not respond to chemotherapy. Enzalutamide is not FDA-approved for breast cancer. It is currently being used for research purposes only in breast cancer patients. The study doctor can explain how these study drugs are designed to work.